D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Raymond James Financial
RJF
$34.1B
| $12M | 0.02% |
223,982
+185,397
| +480% | +$9.94M |
|
727
ACI Worldwide
ACIW
$5.22B
| $12M | 0.02% |
364,119
+94,804
| +35% | +$3.12M |
|
728
Iridium Communications
IRDM
$1.95B
| $12M | 0.02% |
452,456
-139,616
| -24% | -$3.69M |
|
|
VRTSP
729
DELISTED
Virtus Investment Partners, Inc. 7.25% Series D Mandatory Convertible Preferred Stock
VRTSP
| $11.9M | 0.02% |
134,645
+20,970
| +18% | +$1.86M |
|
730
GSK
GSK
$83.5B
| $11.9M | 0.02% |
227,741
-201,939
| -47% | -$10.5M |
|
|
GHDX
731
DELISTED
Genomic Health, Inc.
GHDX
| $11.9M | 0.02% |
169,828
-75,712
| -31% | -$5.3M |
|
732
Imperial Oil
IMO
$46.8B
| $11.9M | 0.02% |
435,169
-876,758
| -67% | -$24M |
|
733
Taylor Morrison
TMHC
$7.03B
| $11.9M | 0.02% |
669,517
-581,148
| -46% | -$10.3M |
|
734
ATI
ATI
$10.5B
| $11.9M | 0.02% |
463,554
-361,007
| -44% | -$9.23M |
|
735
Digital Realty Trust
DLR
$59.6B
| $11.8M | 0.02% |
99,366
+9,472
| +11% | +$1.13M |
|
736
Fastenal
FAST
$54.3B
| $11.7M | 0.02% |
727,136
-1,128,592
| -61% | -$18.1M |
|
737
Evolent Health
EVH
$1.08B
| $11.7M | 0.02% |
927,808
+503,555
| +119% | +$6.33M |
|
738
Viavi Solutions
VIAV
$2.74B
| $11.7M | 0.02% |
942,721
+453,266
| +93% | +$5.61M |
|
739
Canadian Imperial Bank of Commerce
CM
$73.9B
| $11.6M | 0.02% |
294,444
+285,986
| +3,381% | +$11.3M |
|
740
Radian Group
RDN
$4.81B
| $11.5M | 0.01% |
556,462
+158,506
| +40% | +$3.29M |
|
741
HEICO Class A
HEI.A
$35.3B
| $11.5M | 0.01% |
136,986
-7,801
| -5% | -$656K |
|
742
Honda
HMC
$44.3B
| $11.5M | 0.01% |
423,685
-143,403
| -25% | -$3.9M |
|
743
PBF Energy
PBF
$3.31B
| $11.5M | 0.01% |
369,439
-449,612
| -55% | -$14M |
|
744
Gray Television
GTN
$599M
| $11.5M | 0.01% |
+538,063
| New | +$11.5M |
|
|
KNL
745
DELISTED
Knoll, Inc.
KNL
| $11.5M | 0.01% |
607,005
-93,765
| -13% | -$1.77M |
|
746
RB Global
RBA
$22B
| $11.4M | 0.01% |
336,338
+29,626
| +10% | +$1.01M |
|
747
Genworth Financial
GNW
$3.62B
| $11.4M | 0.01% |
2,983,808
+1,018,682
| +52% | +$3.9M |
|
748
Neogen
NEOG
$1.25B
| $11.4M | 0.01% |
397,422
+206,772
| +108% | +$5.93M |
|
749
Entergy
ETR
$40.1B
| $11.4M | 0.01% |
238,216
-1,175,624
| -83% | -$56.2M |
|
750
Teradyne
TER
$18.4B
| $11.4M | 0.01% |
285,377
-142,582
| -33% | -$5.68M |
|